Literature DB >> 10064187

Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy.

P L Choyke1, M J Siegel, A W Craft, D M Green, M R DeBaun.   

Abstract

BACKGROUND: Children with Beckwith-Wiedemann syndrome and idiopathic hemihypertrophy (BWS/HH) are at increased risk for developing Wilms tumor and screening with abdominal sonography is frequently recommended. However, there is a paucity of published data supporting this strategy. The purpose of this study was to determine whether sonographic screening at intervals of 4 months or less reduced the proportion of late-stage Wilms Tumor (WT) in children with BWS/HH. PROCEDURE: A case series analysis was employed to compare the proportion of late-stage (stage III or IV) Wilms tumor in patients with BWS/HH who were screened with sonography (n = 15) to the proportion of late-stage Wilms tumor in unscreened patients with BWS/HH (n = 59). Patients were identified from the BWS Registry and from previously published studies. Screened patients had sonograms at intervals of 4 months or less.
RESULTS: None of the 12 screened children with Wilms tumor had late-stage disease, whereas 25 of 59 (42%) of unscreened children had late-stage Wilms tumor, a difference that was statistically significant (P < 0.003). Three children had false positive screening studies. They were operated on for suspected Wilms tumor but the lesions proved to be complicated renal cysts (n = 2) or nephroblastomatosis (n = 1).
CONCLUSIONS: This study suggests that children with BWS/HH may benefit from screening sonograms at intervals of 4 months or less. However, false positive screening exams may result in unnecessary surgery. Given the rarity of BWS/HH, a larger, prospective international screening study is necessary to determine if the benefits of screening outweigh the risks.

Entities:  

Mesh:

Year:  1999        PMID: 10064187     DOI: 10.1002/(sici)1096-911x(199903)32:3<196::aid-mpo6>3.0.co;2-9

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  25 in total

Review 1.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

Review 2.  Wnt signaling and renal medulla formation.

Authors:  Jing Yu
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

3.  Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives.

Authors:  Kelly A Duffy; Katheryn L Grand; Kristin Zelley; Jennifer M Kalish
Journal:  J Genet Couns       Date:  2017-12-04       Impact factor: 2.537

4.  Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.

Authors:  Peter F Ehrlich; Yueh-Yun Chi; Murali M Chintagumpala; Fredric A Hoffer; Elizabeth J Perlman; John A Kalapurakal; Brett Tornwall; Anne Warwick; Robert C Shamberger; Geetika Khanna; Thomas E Hamilton; Kenneth W Gow; Arnold C Paulino; Eric J Gratias; Elizabeth A Mullen; James I Geller; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome
Journal:  Cancer       Date:  2020-05-27       Impact factor: 6.860

Review 5.  Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice.

Authors:  R H Scott; L Walker; Ø E Olsen; G Levitt; I Kenney; E Maher; C M Owens; K Pritchard-Jones; A Craft; N Rahman
Journal:  Arch Dis Child       Date:  2006-07-20       Impact factor: 3.791

6.  Hemihypertrophy, renal dysplasia and benign nephromegaly.

Authors:  Mohammad Amin Memon; Suravi Mohanty; Kanishka Das; Isha Garg; Ashley Lucien Joseph D'Cruz
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

Review 7.  Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation.

Authors:  Karen W Gripp; Laura Baker; Vinay Kandula; Katrina Conard; Mena Scavina; Joseph A Napoli; Gregory C Griffin; Mihir Thacker; Rachel G Knox; Graeme R Clark; Victoria E R Parker; Robert Semple; Ghayda Mirzaa; Kim M Keppler-Noreuil
Journal:  Am J Med Genet A       Date:  2016-05-18       Impact factor: 2.802

Review 8.  Management of familial cancer: sequencing, surveillance and society.

Authors:  Nardin Samuel; Anita Villani; Conrad V Fernandez; David Malkin
Journal:  Nat Rev Clin Oncol       Date:  2014-10-14       Impact factor: 66.675

9.  Bilateral disease and new trends in Wilms tumour.

Authors:  Catherine M Owens; Hervé J Brisse; Øystein E Olsen; Joanna Begent; Anne M Smets
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 10.  Management and etiology of the unilateral multicystic dysplastic kidney: a review.

Authors:  David S Hains; Carlton M Bates; Susan Ingraham; Andrew L Schwaderer
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.